Vancouver, British Columbia–(Newsfile Corp. – February 16, 2023) –  Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC) (“Xebra”) a cannabis company, announces a 5 to 1 share consolidation and a non-brokered private placement of up to 8,000,000 units of Xebra (the “Units“) priced, on a post-consolidated basis, at $0.075 per Unit for gross proceeds of up to $600,000 (the “Offering“).

Each Unit will be comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant will entitle the holder thereof to acquire one Common Share (a “Warrant Share“) at an exercise price of C$0.10 per Warrant Share at any time for a period of eighteen (18) months following the closing of the Financing.

It is expected that the closing of the Offering will be on or about March 1st, 2023 (the “Closing Date“) or such other date or dates that Xebra may determine, subject to the receipt of all required regulatory approval, including acceptance of the Canadian Securities Exchange (the “CSE“). All securities issued in connection with the Offering will be subject to a hold period of four months and one day from the Closing Date. In connection with the Offering, Xebra may pay finders’ fees in cash or securities, or a combination of both, as permitted by the policies of the CSE.

Xebra intends to consolidate its issued and outstanding share capital on the basis of 1 post-consolidation share for each 5 pre-consolidation common shares (the “Consolidation“). Any fraction of a common share will be rounded up or down to the nearest whole number. The common shares will are expected begin trading on a consolidated basis and with a new CUSIP number on February 28, 2023, subject to the regulatory approvals, including the approval of the CSE.

As a result of the Consolidation, the outstanding common shares of Xebra will be reduced to approximately 39,339,581, on a pre-Offering basis. In the event the Offering is fully subscribed, it is expected that Xebra will have a total of 47,339,581 common shares issued and outstanding.

Shareholders who hold their shares through a securities broker or dealer, bank or trust company will not be required to take any measures with respect to the share consolidation. Xebra’s transfer agent, Computershare Investor Services Inc. (“Computershare“), will mail a letter of transmittal to all registered shareholders of Xebra that will contain instructions for exchanging their pre-Consolidation common shares for post-Consolidation common shares. Registerered shareholers will be required to return their certificates representing pre-Consolidation common shares and a completed letter of transmittal to Computershare. Any registered shareholder who submits a duly completed letter of transmittal to Computershare along with pre-Consolidation share certificate will receive in return a post-Consolidation share certificate or Direct Registration System Advice. Xebra’s outstanding warrants and options will be adjusted on the same basis (1 to 5) as Xebra’s common shares, with proportionate adjustments being made to exercise prices.

Xebra will not be changing its name or trading symbol in connection with the Consolidation.

Trading on a Consolidated Basis: February 28, 2023

Record Date: February 29, 2023

The securities issued under the Offering have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and were not to be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful.

Keith Dolo
Director

Certain information contained in this press release constitutes forward-looking information or forward-looking statements under applicable securities laws. Any statements that are not statements of historical fact may be deemed to be forward-looking statements, these include, without limitation, statements regarding Xebra Brands Ltd.’s expectations in respect of its ability to successfully execute its business plan or business model; its abiaility to close the Offering, the expected number of issued and outstanding common shares on a post-Consolidation basis, the mailing of letters of transmittal, Xebra’s ability to provide economic, environmental, social, or any benefits of any type, in the communities it operates in or may operate it in the future; its ability to be a first mover in a country, or to obtain or retain government licenses, permits or authorizations in general, or specifically in Mexico, Canada, or elsewhere, including cannabis authorizations from the Mexican Health Regulatory Agency (COFEPRIS) and the timing of such permits or authorizations; its ability to successfully apply for and obtain trademarks and other intellectual property in any jurisdiction; its ability to be cost competitive; its ability to commercialize, cultivate, grow, or process hemp or cannabis in Mexico, Canada, or elsewhere and related plans and timing; its ability to manufacture, commercialize or sell cannabis-infused beverages, wellness products, or other products in Mexico, Canada, or elsewhere, and its related plans and claims, including market interest and availability; its ability to create wellness products that have a therapeutic effect or benefit; plans for future growth and the direction of the business; financial projections including expected revenues, gross profits, and EBITDA (which is a non-GAAP financial measure); plans to increase product volumes, the capacity of existing facilities, supplies from third party growers and contractors; expected growth of the cannabis industry generally; management’s expectations, beliefs and assumptions in general, including manufacturing costs, production activity and market potential in Mexico or any jurisdiction; events or developments that XEBRA expects to take place in the future; general economic conditions; and other risk factors described in the prospectus of the Company dated September 30, 2021. All statements, other than statements of historical facts, are forward-looking information and statements. The words “aim”, “believe”, “expect”, “anticipate”, “contemplate”, “target”, “intends”, “continue”, “plans”, “budget”, “estimate”, “may”, “will”, and similar expressions identify forward-looking information and statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by XEBRA as of the dates of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements. Such factors include, but are not limited to, the inability of XEBRA to generate sufficient revenues or to raise sufficient funds to carry out its business plan; changes in government legislation, taxation, controls, regulations and political or economic developments in various countries; risks associated with agriculture and cultivation activities generally, including inclement weather, access to supply of seeds, poor crop yields, and spoilage; compliance with import and export laws of various countries; significant fluctuations in cannabis prices and transportation costs; the risk of obtaining necessary licenses and permits; inability to identify, negotiate and complete a potential acquisition for any reason; the ability to retain key employees; dependence on third parties for services and supplies; non-performance by contractual counter-parties; general economic conditions; and the continued growth in global demand for cannabis products and the continued increase in jurisdictions legalizing cannabis; and the timely receipt of regulatory approval for license applications. In addition, there is no assurance Xebra will: be a low-cost producer or exporter; obtain a dominant market position in any jurisdiction; have products that will be unique. The foregoing list is not exhaustive and XEBRA undertakes no obligation to update or revise any of the foregoing except as required by law. Many of these uncertainties and contingencies could affect XEBRA’s actual performance and cause its actual performance to differ materially from what has been expressed or implied in any forward-looking statements made by, or on behalf of, XEBRA. Readers are cautioned that forwardlooking statements are not guarantees of future performance and readers should not place undue reliance on such forward-looking statements. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those set out in such statements.

For further information: +1 (604) 424-4200, ir@xebrabrands.com CO: Xebra Brands Ltd.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

2022 Consolidated Business Combination Revenue of ~$75,000,000 and Positive Adjusted EBITDA

2023 Consolidated Forecasted Revenue of $100,000,000 and Positive Adjusted EBITDA

BOCA RATON, Fla., Jan. 31, 2023 (GLOBE NEWSWIRE) — Stem Holdings, Inc. (OTCQB: STMH, CSE: STEM) (“Stem” or the “Company”) is pleased to announce that it has executed a term sheet (“Term Sheet”) for a proposed business combination (the “Transaction”) with Headwaters, LLC, (“HDWTR” or “Headwaters”). Pursuant to the Term Sheet, the Transaction will result in a reverse takeover of the Company and, subject to the satisfaction of all listing conditions, the listing of the combined entity on the Canadian Securities Exchange (the “CSE”) and the OTCQB Venture. Following the closing of the Transaction, it is expected that the former equity holders of HDWTR will own approximately 80% of the issued and outstanding shares of the Company.

The Transaction is subject to, among other matters, the execution of a mutually agreeable definitive agreement (the “Definitive Agreement”), completion of due diligence and subject to several conditions including, but not limited to, stockholder approval, delivery of acceptable financial statements, board of directors’ approval and satisfaction of all regulatory and stock exchange approvals. The Transaction is expected to be completed by way of an amalgamation, merger or other form of business combination to be determined by the parties following receipt of securities, corporate and tax law advice.

“Over the past 12 months, Stem has worked tirelessly to find the right company to transact a business combination with. We could not be more excited about combining forces with Headwaters, LLC,” said Matthew Cohen, Chief Executive Officer of Stem. “Not only will this transaction bring world-renowned cultivation processes, but by combining with Stem and our existing footprint of brands and retail locations, we instantly become a pre-eminent vertically integrated and profitable cannabis company with a new platform and a vision to bolster on even more accretive transactions in the future.”

“Currently, Headwaters, located in California is a leading greenhouse cultivator, wholesale and distributor, with an emergent brand called Mr. Zips. We’re ready to grow our business to the next level, and the Stem team enables us to do just that. With access to capital markets and Stem’s valuable network, Headwaters is well positioned to continue disrupting the world’s largest cannabis market and to expand into new territories. We couldn’t think of a better partner to help us achieve our goal of maintaining and continue to be one of California’s largest and most profitable cultivation companies,” said Tristan Strauss, Founder and CEO of Headwaters.

About Stem Holdings:

Stem is a leading cannabis and hemp branded products company in the U.S. with proprietary capabilities in sustainable cultivation, processing, extraction, and R&D, as well as retail and distribution operations aligned with state-by-state regulations. Stem’s award-winning owned and partner-brands including TJ’s Gardens and Yerba Buena are the foundation of the Company’s expansion within current as well as new segments and markets, with exceptional and disruptive brands, and products that benefit well-being. Stem’s expertise and scale will drive growth domestically and internationally with a continuing commitment to social responsibility and shareholder equity as a leader in the cannabis industry.

About Headwaters:

Headwaters’ origin story is humble and authentic, born a decade ago in Humboldt County as a small outdoor medical farm. Despite its small beginnings, Headwaters’ vision is predicated on executing across core values of community, sustainability, and operational excellence. Headwaters owes the entirety of its success to our team and leadership’s dedication to these values.

Over the past five years the business has experienced rapid growth in highly volatile market conditions. Headwaters ventured into consumer products in 2017 by supplying the first white label products on California’s largest e-commerce delivery platform. Two years later the company launched a novel comprehensive partnership program that supported farmers up and down the state with nursery, cultivation management, post-harvest processing, and distribution services. Since then, Headwaters has been widening its intellectual property moat through genetic selection, SOP optimization, and development of its proprietary technology, Cultivation Grid©. Headwaters it is well positioned to operate at scale efficiently and effectively.

• Headquartered in Carpinteria, CA
• Chief Executive Officer and Founder Tristan Strauss is a proven leader in horticultural agriculture and cannabis business. Mr. Strauss co-founded two California medical cannabis companies previously: Canigou Inc. and Helios, both known as the brand, State Wellness.
• Operates four greenhouses in the Carpinteria area totaling over 23 acres of production and nursery canopy
• Company has 4 distinct sales channels:
  • Bulk Wholesale: Sourcing and selling of cannabis flower, smalls, trim, and derivative products in bulk format
  • Agricultural Services: Selling of clones propagated and rooted from proprietary genetics and partnerships
  • Branded Products: Development and sale of CPG products into licensed retail channels
  • Technology Services: Proprietary IP for cultivation and post-harvest processing
• Sold 230,000 pounds of bulk cannabis and 1,700,000 clones in 2021

Reader Advisory

Completion of the Transaction is subject to a number of conditions, including but not limited to CSE acceptance. There can be no assurance that the Transaction will be completed as proposed or at all. The CSE has in no way passed upon the merits of the proposed Transaction and has neither approved nor disapproved the contents of this press release.

Cautionary Note Regarding Forward-Looking Information

This press release contains statements that constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the management of Stem with respect to future business activities. Forward-looking information is often identified by the words “may,” “would,” “could,” “should,” “will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” or similar expressions and includes information regarding: (i) the ability of the surviving entity to integrate the combined operations of the parties; (ii) the closing of the Transaction, together with expectations around the accretive nature of the Transaction; (iii) the expansion of the surviving entity’s market following the closing of the Transaction and the ability to scale operations; (iv) the expected cost savings and other efficiencies following the closing of the Transaction; and (v) the forecasted revenue and EBITDA of the combined company. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects the management of the Company’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the surviving entity. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; the ability of the surviving entity to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; construction delays; decreases in the prevailing prices for cannabis and cannabis products in the markets that the surviving entity will maintain operations; adverse changes in applicable laws; adverse changes in the application or enforcement of current laws, including those related to taxation; the inability to locate and acquire suitable companies, properties and assets necessary to execute on the surviving entity’s business plans; political risk; and increasing costs of compliance with extensive government regulation. This forward-looking information may be affected by any number of risks and uncertainties affecting the business of the surviving entity and applicable market conditions.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated, or expected. Although the parties to the Transaction have attempted to (and will continue efforts) to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not assume any obligation to update this forward-looking information except as otherwise required by applicable law.

No securities regulatory authority has in any way passed upon the merits of the proposed transactions described in this news release or has approved or disapproved of the contents of this news release.

Financial Outlook

This news release contains a financial outlook within the meaning of applicable securities laws. The financial outlook has been prepared by management of the Company to provide an outlook for the Company’s and Headwaters’ forecasted revenue and EBITDA and may not be appropriate for any other purpose. The financial outlook has been prepared based on a number of assumptions including the assumptions discussed under the heading “Cautionary Note Regarding Forward-Looking Statements”. The actual results of the Company’s operations for any period will likely vary from the amounts set forth in these projections and such variations may be material. The Company and its management believe that the financial outlook has been prepared on a reasonable basis. However, because this information is highly subjective and subject to numerous risks, including the risks discussed under the heading “Cautionary Note Regarding Forward-Looking Statements”, it should not be relied on as necessarily indicative of future results.

Media Contact:
Regina Costa
Director of Public Relations
561-948-5410
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Vancouver, British Columbia–(Newsfile Corp. – October 25, 2022) – World Class Extractions Inc. (CSE: PUMP) (FSE: WCF) (OTCQB: WCEXF) (the “Corporation” or “World-Class“) is providing this bi-weekly default status report (the “Default Status Report“) in accordance with National Policy 12-203 – Management Cease Trade Orders (“NP 21-203“). On August 15, 2022, the Corporation announced (the “Default Announcement“) that, for reasons disclosed in the Default Announcement, the filing of the Corporation’s audited financial statements for the financial year ended April 30, 2022, and the related management’s discussion and analysis, and Chief Executive Officer and Chief Financial Officer certificates (collectively, the “Annual Filings“) would not be completed by the prescribed deadline of August 29, 2022.

As a result of this delay in filing the Annual Filings, the Corporation’s principal regulator, British Columbia Securities Commission, granted a temporary management cease trade order (the “MCTO“) to the Corporation on August 30, 2022. The MCTO prohibits all trading by the Chief Executive Officer and the Chief Financial Officer of the Corporation, and such other directors, officers and persons as determined by the applicable regulatory authorities, in securities of the Corporation until the MCTO is revoked. The Corporation’s board of directors and management confirm that they are working expeditiously to meet the Corporation’s obligations relating to the filing of the Annual Filings, with the goal of filing prior to October 28, 2022.

Pursuant to the provisions of the alternative information guidelines specified by NP 12-203, the Corporation reports that since the Default Announcement there have not been any changes to the information contained therein that would reasonably be expected to be material to an investor, not any failure by the Corporation to fulfill its intentions as stated therein with respect to satisfying the provisions of the alternative information guidelines, and there are no additional defaults or anticipated defaults subsequent to the disclosure therein, other than the delay in filing the Annual Filings.

Further, there is no additional material information respecting the Corporation and its affairs that have not been generally disclosed and there are no insolvency proceedings against the Corporation as of the date of this Default Status Report. Until the Annual Filings have been filed, the Corporation intends to continue to satisfy the provision of the alternative information guidelines specified by NP 12-203 by issuing bi-weekly status default reports in the form of press releases, which will also be filed on SEDAR at www.sedar.com.

About World Class Extractions Inc.

World-Class is an innovation-driven company and has been approved by its shareholders to change its business from a company focused on the cannabis industry to that of an investment issuer with a focus on the life sciences industries (the “Proposed Change of Business“). Subject to regulatory and Canadian Securities Exchange (the “CSE“) approval with respect to the Proposed Change of Business, World-Class intends to focus its business on investing in private and public companies with strong intellectual property, exceptional management and high growth potential that may be strategically positioned in the global market. World-Class recently disposed of its wholly owned subsidiary, Soma Labs Scientific Inc., a designer, manufacturer, and supplier of extraction and processing equipment and solutions.

On behalf of the Board of Directors of
WORLD CLASS EXTRACTIONS INC.

Rosy Mondin
Chief Executive Officer
[email protected]

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

This news release contains certain forward-looking information within the meaning of applicable Canadian securities laws (“forward-looking statements“). All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “anticipate”, “achieve”, “could”, “believe”, “plan”, “intend”, “objective”, “continuous”, “ongoing”, “estimate”, “outlook”, “expect”, “project” and similar words, including negatives thereof, suggesting future outcomes or that certain events or conditions “may” or “will” occur. These statements are only predictions. Forward-looking statements in this press release include, but are not limited to, statements relating to the expected timing of the filing of the annual audited financial statements and related management’s discussion and analysis for the financial year ended April 30, 2022, the continued satisfaction of the requirements of the MCTO, statements in respect of the Corporation’s ability to obtain approval from the CSE for the Proposed Change of Business, statements relating to expected benefits of the Proposed Change of Business to the Corporation and its shareholders or statements relating to the completion of the Proposed Change of Business and direction of the business and future plans or prospects of the Corporation following the Proposed Change of Business.

Forward-looking statements are based on the opinions and estimates of management of the Corporation at the date the statements are made based on information then available to the Corporation. Various factors and assumptions are applied in drawing conclusions or making the forecasts or projections set out in forward-looking statements. Forward-looking statements are subject to and involve a number of known and unknown variables, risks and uncertainties, many of which are beyond the control of the Corporation. Such factors, among other things, include regulatory and other approvals or consents; fluctuations in general macroeconomic conditions; fluctuations in securities markets; impact of the COVID-19 pandemic and political and social uncertainties.

No assurance can be given that the expectations reflected in forward-looking statements will prove to be correct. The Completion of the Proposed Change of Business and subject to a number of conditions, including the CSE acceptance and approval. The transaction cannot be completed until the required approvals has been obtained. There can be no assurance that the transaction will be completed as proposed or at all. Although the forward-looking statements contained in this news release are based upon what management of the Corporation believes, or believed at the time, to be reasonable assumptions, the Corporation cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. Additional information regarding risks and uncertainties relating to the Corporation’s business are contained in the Corporation’s management discussion and analysis filed on its issuer profile on SEDAR at www.sedar.com. The forward-looking statements contained in this press release are made as of the date of this press release, and the Corporation does not undertake to update any forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Investors are cautioned that, except as disclosed in the listing statement to be prepared in connection with the Proposed Change of Business, any information released or received with respect to the Proposed Change of Business may not be accurate or complete and should not be relied upon. Trading in the securities of the Corporation should be considered highly speculative.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

NORWOOD, Mass., April 07, 2022 (GLOBE NEWSWIRE) — MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced that it has filed a preliminary non-offering long form prospectus (the “Prospectus”) with the securities regulatory authorities in the Provinces of Ontario and British Columbia. No securities are being sold pursuant to the Prospectus and no proceeds are being raised.

The Company also announced that it has applied to list its common shares (“Common Shares”) on the Canadian Securities Exchange (the “CSE”). Listing and trading of the Common Shares will be subject to the Company fulfilling all the CSE’s listing requirements and the Company being receipted for a final prospectus with the securities regulatory authorities in the Provinces of Ontario and British Columbia.

“We are excited to announce this significant milestone of applying for a dual listing on the CSE,” said Robert Fireman, Chief Executive Officer of MariMed. “We believe the potential trading of our Common Shares on the CSE will increase liquidity for our shareholders, and provide access to a significant pool of prospective retail and institutional investors in addition to our current long-term investors we have on the OTCQX market.”

A copy of the Prospectus is available under the Company’s profile on SEDAR at www.sedar.com. There can be no guarantee that a receipt for the final prospectus will be obtained from the securities regulatory authorities in the Provinces of Ontario and British Columbia or that the CSE will accept the listing of the Common Shares.

ABOUT MARIMED
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty’s Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.

For More Information, Contact:

Investor Relations:
Steve West, Vice President, Investor Relations
Email: [email protected]

Media Contact:
Howard Schacter, Chief Communications Officer
Email: [email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

California has the world’s largest cannabis market with an estimated $12 billion in annual sales. While legal cannabis sales topped $3 billion last year, the state continues to struggle to meet high expectations with logistical and other challenges.

ManifestSeven Holdings Corporation (CSE: MSVN), which recently debuted on the Canadian Securities Exchange on September 30, aspires to solve many of these problems with its innovative business model designed to connect enterprises operating across legal cannabis supply chain — from cultivator to retailer, and everyone in between — to consumers in a more uniform and familiar manner, and without all of the overhead. In essence, it’s building the ‘Amazon of Cannabis’ with service stretching from Sacramento to San Diego and extending across the value chain.

Let’s take a look at ManifestSeven’s resilient management team and how it plans to scale revenue and grow shareholder value over the coming months.

From Railroads to Fiber

ManifestSeven is often referred to as the ‘Amazon of Cannabis’, but like Amazon.com, there’s a lot more to the business than its public facing website. Amazon.com relies on an extensive distribution network that includes its own fleet of vehicles and cargo airline, as well as a network of more than 175 fulfillments centers around the world.

CEO Sturges Karban explains what investors can expect in the coming year:

ManifestSeven doesn’t have the same distribution capacity, mainly because it faces several more barriers when it comes to selling highly regulated cannabis products. Nonetheless, the company has spent the past few years building out and integrating the physical infrastructure that now supports its growing distribution services and retail businesses, including its network of distribution centers and dispensaries across the state of California—from Sacramento to San Diego.

This nascent “laying of the railroads” phase, as CEO Sturges Karban describes it — which was very focused on assembling the nuts and bolts of M7’s physical infrastructure — is increasingly ready for an upgrade into a more modern, “fiber optic” network. As the company pivots to rolling out additional services, many of which will be underpinned by technology platforms familiar to businesses and consumers alike from other industries, the sophistication and reach of the company’s distribution and retail platforms can only grow stronger and deeper; while the company is already generating growing revenue and closing in on profitability, the team plans to scale its market footprint and increase customer penetration by aggressively exploiting its 1-800-CANNABIS brand and technology assets over the coming year.

Resilient Management Team

ManifestSeven had spent three years building a resilient business model before the COVID-19 pandemic hit. Despite the impact of the pandemic, between Q1 and Q2 of 2020, the company managed to increase revenue by 25% quarter over quarter, reduce its net burn by over 70% and complete a capital raise during a period of capital starvation—a testament to its strong business model and leadership team.

Listen to CEO Sturges Karban on why MSVN is attractive to investors:

 The company’s management team is led by CEO Sturges Karban, a Harvard-educated businessman who has more than 20 years of experience across capital markets, investment banking, asset management and high-growth operations. Prior to joining the company in 2014, he co-founded Meridian Advisors, a boutique consultancy in LA, NYC and London.

Sturges is joined in the C-suite by a number of executives who share a similar background and pedigree. Urban Smedeby, the President of the company, has 30 years of experience in the global capital markets, with a principal focus on affinity industries, such as life sciences. The company’s Chief Investment Officer hails from CIM Group, California’s largest real estate private equity fund. Dilshad Kasmani, M7’s Chief Legal Officer and General Counsel, practiced at Andrews Kurth LLP and Paul Hastings LLP, before going in-house at Cardtronics plc (NASDAQ: CATM) and then American Midstream Partners LP (NYSE: AMID). In addition to this resident strategic and financial experience, the company’s C-suite includes Chief Operating Officer Pierre Rouleau, an entrepreneurial executive with repeated successes in the regulated cannabis, high-tech, and aviation industries; prior to ManifestSeven, Pierre was the Chairman and COO of cannabis dispensary operator, ShowGrow, where he helped expand that company’s retail presence into multiple locations across California and Nevada during the early days of statewide legalization, bringing to the table longstanding channel, operational, and industry relationships, experience, and expertise. 

Looking Ahead

ManifestSeven Holdings Corporation (CSE: MSVN) has built a dynamic business that expects to encounter numerous catalysts over the coming months. With plans to scale revenue through its 1-800-CANNABIS brand and technology assets, investors may want to take a closer look at the stock. On September 30, the company debuted on the Canadian Securities Exchange under the ticker symbol MSVN, making it accessible to retail traders and investors.

For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.